We describe the development and implementation of a system for monitoring patient-reported adverse events and quality of life using electronic Patient Reported Outcome (ePRO) instruments in the I-SPY2 Trial, a phase II clinical trial for locally advanced breast cancer. We describe the administration of technological, workflow, and behavior change interventions and their associated impact on questionnaire completion.
Author(s): Northrop, Anna, Christofferson, Anika, Umashankar, Saumya, Melisko, Michelle, Castillo, Paolo, Brown, Thelma, Heditsian, Diane, Brain, Susie, Simmons, Carol, Hieken, Tina, Ruddy, Kathryn J, Mainor, Candace, Afghahi, Anosheh, Tevis, Sarah, Blaes, Anne, Kang, Irene, Asare, Adam, Esserman, Laura, Hershman, Dawn L, Basu, Amrita
DOI: 10.1093/jamia/ocae190